Article Image
News Link • Science, Medicine and Technology

Israel Develops Cancer Vaccine to Halt Resurgence

• arclein
axil’s lead product, ImMucin, activates the immune system by “training” T-cells –– the immune cells that protect the body by searching out and destroying cells that display a specific molecule (or marker) called MUC1. MUC1 is typically found only on cancer cells an

Join us on our Social Networks:


Share this page with your friends on your favorite social network: